• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM Back to Search Results
Model Number MI1200 SYNCHRONY PIN
Device Problem Device Appears to Trigger Rejection (1524)
Patient Problem Electric Shock (2554)
Event Type  Injury  
Manufacturer Narrative
The device has not been explanted.If it should be explanted, it is to be returned to the manufacturer for evaluation.When available, a device failure analysis will be submitted as a follow up report.
 
Event Description
In (b)(6) 2020 an implant exposure was seen from the skin behind the ear.Furthermore, the electrode had extruded into the external auditory canal.An infection was confirmed.Explantation is scheduled for the (b)(6) 2020.
 
Manufacturer Narrative
Conclusion: device investigation did not reveal any device defect or damage, which has been present whilst implanted.Mechnical damages found during investigation are attributable to the removal surgery.This finding was expected because the device was explanted due to an implant exposure through the skin.Further the electrode extruded into the external ear canal.According to the information received, the recipient had a canal wall down mastoidectomy likely due to a chronic middle ear disease, including the reported cholesteatoma.The reported surgical approach is known to bear the risk of lead extrusion through the posterior ear canal.In addition, ongoing infection at the implant site has been observed and several auricular cultures were able to isolate different pathogens.Considering the proper sterilization of the device and the type of pathogens isolated, the reported infection and subsequent device exposure was likely due to colonization of the surgical site at the time of surgery.This is a final report.
 
Event Description
In (b)(6) 2020 an implant exposure was seen from the skin behind the ear by the incision site.According to the device explantation report form on the (b)(6) 2020 a cutaneous fistula developed in the posterior part of the auricle and was drained.The skin defect didn't improve with treatment and enlarged exposing the implant.Furthermore, the electrode had extruded into the external auditory canal.An infection was confirmed.Auricular cultures obtained in different time periods, isolated several bacteria, including corynebacterium, p.Aeruginosa and cns.The user was explanted on the (b)(6) 2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MED-EL MAESTRO COCHLEAR IMPLANT SYSTEM
Type of Device
COCHLEAR IMPLANT
Manufacturer (Section D)
MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
innsbruck
AU 
MDR Report Key11443208
MDR Text Key238661833
Report Number9710014-2021-00151
Device Sequence Number1
Product Code MCM
UDI-Device Identifier09008737094058
UDI-Public(01)09008737094058
Combination Product (y/n)N
PMA/PMN Number
P000025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberMI1200 SYNCHRONY PIN
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/01/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 02/25/2021
Initial Date FDA Received03/09/2021
Supplement Dates Manufacturer Received02/25/2021
Supplement Dates FDA Received05/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-